BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3754599)

  • 21. Biological characterization of A-ring steroids.
    Johnston JO; Wright CL; Burkhart JP; Peet NP
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biochemical properties of 6-bromoandrostenedione derivatives with a 2,2-dimethyl or 2-methyl group as aromatase inhibitors.
    Numazawa M; Handa W; Yamada K
    Biol Pharm Bull; 2004 Nov; 27(11):1878-82. PubMed ID: 15516742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
    Brueggemeier RW; Floyd EE; Counsell RE
    J Med Chem; 1978 Oct; 21(10):1007-11. PubMed ID: 722711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.
    Bellino FL; Gilani SS; Eng SS; Osawa Y; Duax WL
    Biochemistry; 1976 Oct; 15(21):4730-6. PubMed ID: 974087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
    Johnston JO; Wright CL; Holbert GW; Benson HD
    J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of thiol-containing androgens with human placental aromatase.
    Bednarski PJ; Nelson SD
    J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
    Numazawa M; Mutsumi A; Tachibana M; Yoshimura A
    Biol Pharm Bull; 2003 Jun; 26(6):890-2. PubMed ID: 12808307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors.
    Lovett JA; Darby MV; Counsell RE
    J Med Chem; 1984 Jun; 27(6):734-40. PubMed ID: 6547488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromatase.
    Njar VC; Düerkop J; Hartmann RW
    J Enzyme Inhib; 1996; 10(1):47-56. PubMed ID: 8835929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Methylene-substituted androgens as novel aromatization inhibitors. Evidence of a requirement for C-3 oxygen in C-19 hydroxylations.
    Miyairi S; Fishman J
    J Biol Chem; 1986 May; 261(15):6772-7. PubMed ID: 3700413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase inhibition by 4-thiosubstituted-4-androstene-3,17-dione derivatives.
    Abul-Hajj YJ
    J Steroid Biochem; 1990 Jan; 35(1):139-43. PubMed ID: 2308324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereochemistry of the functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione.
    Osawa Y; Osawa Y; Coon MJ
    Endocrinology; 1987 Sep; 121(3):1010-6. PubMed ID: 3622372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
    Numazawa M; Mutsumi A; Tachibana M
    Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of human placental aromatase by 6 alpha- and 6 beta-hydroperoxyandrostenedione.
    Tan L; Petit A
    Biochem Biophys Res Commun; 1985 Apr; 128(2):613-20. PubMed ID: 3994715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs.
    Numazawa M; Watari Y; Yamada K; Umemura N; Handa W
    Steroids; 2003 Aug; 68(6):503-13. PubMed ID: 12906935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors.
    Li PK; Brueggemeier RW
    J Med Chem; 1990 Jan; 33(1):101-5. PubMed ID: 2296006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covalent modification of aromatase by a radiolabeled irreversible inhibitor.
    Snider CE; Brueggemeier RW
    J Steroid Biochem; 1985 Mar; 22(3):325-30. PubMed ID: 3990283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel irreversible aromatase inhibitors.
    di Salle E; Giudici D; Briatico G; Ornati G
    Ann N Y Acad Sci; 1990; 595():357-67. PubMed ID: 2375613
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
    Numazawa M; Yoshimura A; Oshibe M
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroidal inhibitors as chemical probes of the active site of aromatase.
    Brueggemeir RW; Moh PP; Ebrahimian S; Darby MV
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):357-65. PubMed ID: 8476749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.